Future Patients
“I want options for minimally invasive relief”
Patients in need of pain relief are often faced with a choice between quick, non-invasive drug treatments and more invasive, device-based solutions. While drugs like steroids and opioids can provide temporary relief, they come with the risk of side effects and addiction. Conversely, traditional device-based neuromodulation has been less accessible due to its invasive nature and higher costs, often reserved as a last resort after other therapies have been exhausted.
Neuronoff's Injectrode system is changing this narrative by offering an earlier, drug-free treatment option. Its minimally invasive nature provides a practical alternative to both drugs and more invasive devices. With the Injectrode, patients can trial neuromodulation therapy with a Try Lead for 30 days, avoiding the commitment of surgery and the risk of scars. This approach not only makes neuromodulation more accessible but also allows for earlier intervention in the treatment process, aligning with insurance providers’ preferences for cost-effective solutions.
Physicians
“I want options for minimally invasive relief”
Physicians are often on the lookout for new, efficient pain management methods that fit seamlessly into their practice. Neuronoff's Injectrode offers just that. Its design allows physicians to trial neuromodulation therapy early in the treatment cycle, crucial for assessing whether a patient positively responds to the approach. This early intervention potential is a game-changer, offering tailored patient care without disrupting the routine clinical workflow. Moreover, the Injectrode’s simple, swift procedure for both placement and removal means it can easily be incorporated into a physician's daily schedule.
The Injectrode system also addresses common concerns in device-based treatments. Its minimally invasive application means less risk of infection or device movement, key considerations for any clinician. Additionally, the reduced recovery time and minimal post-op pain associated with the Injectrode placement further align with the physician's goal of providing patient-centered, effective care. By simplifying the entire process and reducing potential complications, the Injectrode system is set to become a preferred choice for physicians looking to offer advanced, yet uncomplicated, pain relief solutions.